SKI Market

Indian Indices

Sensex

83,085.40 -228.53
( -0.27%)

Global Indices

Nasdaq

48,934.28 -588.03
(-1.19%)

Dow Jones

6,820.12 -83.60
(-1.21%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,300.09 -102.25
(-0.98%)

Forex

USD-INR

90.39 0.07
(0.07%)

EUR-INR

106.79 0.14
(0.13%)

GBP-INR

123.73 0.13
(0.10%)

JPY-INR

0.58 0.00
(-0.49%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Relonchem receives UK MHRA's marketing approval for two products

Nov 17,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA:

1. Mefenamic Acid 250 mg Film-Coated Tablets
2. Mefenamic Acid 500 mg Film-Coated Tablets

83,085.40 -228.53 ( -0.27%)

48,934.28 -588.03 (-1.19%)

6,820.12 -83.60 (-1.21%)

54,176.23 358.19 (0.67%)

10,300.09 -102.25 (-0.98%)

90.39 0.07 (0.07%)

106.79 0.14 (0.13%)

123.73 0.13 (0.10%)

0.58 0.00 (-0.49%)